Disclosures for "Results from the Global Phase 3 Trial (IB1001-303) Evaluating Levacetylleucine in Children and Adults with Ataxia-Telangiectasia"
-
Dr. Patterson has received personal compensation for serving as an employee of IntraBio. The institution of Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme /KemPharm/Zevra. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azafaros. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IntraBio. Dr. Patterson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. Dr. Patterson has or had stock in IntraBio. The institution of Dr. Patterson has received research support from Glycomine. The institution of Dr. Patterson has received research support from Orphazyme /KemPharm/Zevra. The institution of Dr. Patterson has received research support from Idorsia. The institution of Dr. Patterson has received research support from Shire-Takeda. Dr. Patterson has received publishing royalties from a publication relating to health care. Dr. Patterson has received publishing royalties from a publication relating to health care.
-
Dr. Bremova-Ertl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrabio. The institution of Dr. Bremova-Ertl has received research support from InnoSuisse. Dr. Bremova-Ertl has received research support from Baasch-Medicus.
-
Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has stock in IntraBio.
-
Dr. Kerthi has received personal compensation for serving as an employee of IntraBio, Inc. Dr. Kerthi has received personal compensation for serving as an employee of Amylyx Pharmaceuticals, Inc. Dr. Kerthi has stock in IntraBio, Inc. Dr. Kerthi has stock in Amylyx Pharmaceuticals, Inc.
-
Dr. Schafer has received personal compensation for serving as an employee of IntraBio. Dr. Schafer has stock in Amylyx Pharmaceuticals .
-
Bethany Zanrucha has stock in IntraBio. Bethany Zanrucha has stock in Sarepta.
-
Dr. Hatcher has received personal compensation for serving as an employee of IntraBio. Dr. Hatcher has stock in IntraBio.
-
Taylor Fields has received personal compensation for serving as an employee of IntraBio Inc. Taylor Fields has stock in IntraBio. Taylor Fields has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Billington has received personal compensation for serving as an employee of IntraBio Inc. Mr. Billington has stock in IntraBio Inc.
-
Kyriakos Martakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eversana.